Effects of Clinical Pilates on Physical and Psychosocial Outcomes in Individuals With Interstitial Lung Disease

NCT07411066 | Not Yet Recruiting

• 1 other identifier: 2025/012-1758
• Study Type: interventional
• Target: 58
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study aims to investigate the effects of Clinical Pilates on physical and psychosocial outcomes in individuals with interstitial lung disease (ILD). Interstitial lung disease is a group of chronic conditions that affect lung tissue and can lead to breathing difficulties, reduced physical capacity, fatigue, and decreased quality of life. In addition to medical treatment, exercise-based rehabilitation approaches may help individuals with ILD improve their physical function and overall well-being. Clinical Pilates is a structured exercise method that focuses on breathing control, posture, core stability, flexibility, and body awareness. Participants in this study will be randomly assigned to either a Clinical Pilates group or a control group receiving standard care. The Clinical Pilates program will be delivered by a trained physiotherapist over several weeks through supervised sessions. The main outcomes of this study include physical function, respiratory symptoms, quality of life, and psychological well-being. The results of this study are expected to provide evidence on whether Clinical Pilates can be an effective and safe supportive approach for pulmonary rehabilitation in individuals with interstitial lung disease.

Conditions

Interstitial Lung Disease (ILD)

Keywords

interstitial lung disease; clinical pilates; pilates

Outcome Measures

Primary Outcomes (2)

• Six-Minute Walk Test Distance

  Physical function will be assessed using the Six-Minute Walk Test (6MWT). Total walking distance will be recorded.

  Baseline (Week 0) and Week 8

• Modified Medical Research Council Dyspnea Scale Score

  Respiratory symptom severity will be assessed using the Modified Medical Research Council (mMRC) Dyspnea Scale total score. Points (range 0-4; higher scores indicate worse dyspnea)

  Baseline (Week 0) and Week 8

Study Arms (2)

Clinical Pilates Group

EXPERIMENTAL

Participants will receive a structured Clinical Pilates program delivered by a trained physiotherapist, focusing on breathing control, posture, core stability, flexibility, and functional movement.

Behavioral: Clinical Pilates; Other: standart care

Standard Care Control Group

ACTIVE COMPARATOR

Participants will receive standard medical care for interstitial lung disease without additional structured exercise or Clinical Pilates intervention.

Other: standart care

Interventions

Clinical Pilates BEHAVIORAL

A supervised Clinical Pilates exercise program conducted by a physiotherapist, including breathing-focused, posture-based, and low-impact strengthening and flexibility exercises tailored to individuals with interstitial lung disease.

Clinical Pilates Group

standart care OTHER

Participants will continue their usual medical treatment and routine clinical follow-up for interstitial lung disease without additional rehabilitation intervention.

Clinical Pilates Group; Standard Care Control Group

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 18 to 75 years.
• Clinically confirmed diagnosis of interstitial lung disease (ILD) by a physician.
• Clinically stable condition (no acute exacerbation or hospitalization related to ILD within the last 4 weeks).
• On stable medical treatment and routine follow-up.
• Able to walk and participate in low-to-moderate intensity exercise as determined by the clinician/physiotherapist.
• Able to understand study procedures and provide written informed consent.

You may not qualify if:

• Coexisting chronic respiratory disease that may confound outcomes (e.g., COPD, uncontrolled asthma, bronchiectasis).
• Acute exacerbation of ILD or hospitalization within the last 4 weeks.
• Unstable cardiovascular disease or other medical conditions making exercise unsafe (e.g., unstable angina, recent myocardial infarction).
• Severe neurological, musculoskeletal, or balance disorders limiting safe participation in exercise.
• Pulmonary hypertension or oxygen dependency requiring unstable/high-flow support if judged unsafe for exercise participation by the treating clinician.
• Current participation in another structured exercise / pulmonary rehabilitation program during the study period.
• Major psychiatric disorder or cognitive impairment interfering with participation or adherence.
• Pregnancy.

Sponsors & Collaborators

• Recep Tayyip Erdogan University: lead
• İstanbul Yeni Yüzyıl Üniversitesi: collaborator

MeSH Terms

Conditions

Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr

Model Details: Participants will be randomly assigned to one of two parallel groups: a Clinical Pilates intervention group and a control group receiving standard care. Outcomes will be compared between groups at baseline and after completion of the intervention period.

Study Record Dates

• First Submitted: January 31, 2026
• First Posted: February 13, 2026
• Study Start: February 1, 2026
• Primary Completion: April 1, 2026
• Study Completion: May 1, 2026
• Last Updated: February 13, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share